The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase I QTc study of tivozanib in patients with advanced solid tumors.
Manpreet Kaur Chadha
No relevant relationships to disclose
Jeffrey R. Infante
No relevant relationships to disclose
Monette M. Cotreau
Employment or Leadership Position - AVEO
Stock Ownership - AVEO
Lindsey Jacobson
Employment or Leadership Position - AVEO
Stock Ownership - AVEO
Andrew Louis Strahs
Employment or Leadership Position - AVEO
Stock Ownership - AVEO
William Slichenmyer
Employment or Leadership Position - AVEO
Stock Ownership - AVEO
Dennis Vargo
Employment or Leadership Position - AVEO
Stock Ownership - AVEO
Kathleen N. Moore
No relevant relationships to disclose